Clinical trial

Extracellular Vesicles Infusion Treatment for Mild-to-Moderate COVID-19

NCT05125562

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2022-12-07

PhasePHASE2

Study timeline

Study start (estimated)2022-12-07Date precision: day

Registry last updated2024-02-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

COVID-19unresolved

Interventions

ExoFloDRUG

Sponsors & collaborators

Direct Biologics, LLClead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05125562 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.